Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS

• 收藏
• 分享

专利权人:

Yeda Research and Development Co. Ltd.

发明人:

Eisenbach-Schwartz, Michal,Baruch, Kuti,Rosenzweig, Neta

申请号：

AU2020201602

公开号：

AU2020201602A1

申请日:

2020.03.04

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

#$%^&*AU2020201602A120200319.pdf#####ABSTRACT: A pharmaceutical composition comprising an active agent that causes reduction of the level of systemic immunosuppression in an individual for use in treating a disease, disorder, condition or injury of the CNS that does not include the autoimmune neuroinflammatory disease, relapsing- remitting multiple sclerosis (RRMS), is provided. The pharmaceutical composition is for administration by a dosage regimen comprising at least two courses of therapy, each course of therapy comprising in sequence a treatment session followed by an interval session.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/